In summary, the role of cytokines in leukemia cell survival and proliferation makes IL-3 and IL-7 potential therapeutic targets for obesity-driven B-cell ALL, while IL-7 alone may be a target for obesity-driven T-cell ALL. This evidence concerns the gene IL7 and T-cell acute lymphoblastic leukemia.